SeaBridge Investment Advisors’s iShares Biotechnology ETF IBB Stock Holding History

SeaBridge Investment Advisors’s Portfolio IBB Stock Details IBB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$331K	Sell	1,742 -482	-22%	-$82.8K	0.05%	159
2026 Q1	$376K	Sell	2,224 -582	-21%	-$99.5K	0.06%	148
2025 Q4	$474K	Buy	2,806 +92	+3%	+$14.9K	0.08%	148
2025 Q3	$392K	Sell	2,714 -1,301	-32%	-$178K	0.06%	157
2025 Q2	$508K	Sell	4,015 -1,675	-29%	-$206K	0.09%	142
2025 Q1	$728K	Sell	5,690 -403	-7%	-$54.6K	0.16%	116
2024 Q4	$806K	Buy	+6,093	New	+$857K	0.17%	114
2020 Q4	–	Sell	-600	Closed	-$81K	–	190
2020 Q3	$81K	Buy	600 +100	+20%	+$13.6K	0.03%	145
2020 Q2	$68K	Hold	500	–	–	0.03%	159
2020 Q1	$54K	Hold	500	–	–	0.02%	162
2019 Q4	$60K	Hold	500	–	–	0.02%	165
2019 Q3	$50K	Hold	500	–	–	0.02%	177
2019 Q2	$55K	Hold	500	–	–	0.02%	176
2019 Q1	$56K	Hold	500	–	–	0.02%	173
2018 Q4	$48K	Hold	500	–	–	0.02%	173
2018 Q3	$61K	Hold	500	–	–	0.02%	161
2018 Q2	$55K	Buy	+500	New	+$53.5K	0.01%	166
2014 Q2	–	Sell	-10,569	Closed	-$833K	–	234
2014 Q1	$833K	Sell	10,569 -7,677	-42%	-$640K	0.19%	90
2013 Q4	$1.38M	Sell	18,246 -120	-0.7%	-$8.51K	0.31%	87
2013 Q3	$1.28M	Buy	+18,366	New	+$1.2M	0.31%	91

Other funds holding IBB

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

SeaBridge Investment Advisors's IBB Position: Q2 2026 in Review

SeaBridge Investment Advisors reduced its iShares Biotechnology ETF (IBB) stake by 22% in Q2 2026, selling an estimated $82.8K and leaving 1,742 shares worth $331K. The position accounts for 0.05% of the portfolio, ranked #159.

SeaBridge Investment Advisors first reported a position in IBB in Q3 2013 and has held it in 20 quarters since. The position peaked at $1.38M in Q4 2013. 954 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

SeaBridge Investment Advisors held 1,742 shares of iShares Biotechnology ETF worth $331K as of Q2 2026.
SeaBridge Investment Advisors sold 482 iShares Biotechnology ETF shares in Q2 2026, an estimated $82.8K.
iShares Biotechnology ETF made up 0.05% of SeaBridge Investment Advisors's portfolio in Q2 2026, its #159 holding.
SeaBridge Investment Advisors first reported a position in iShares Biotechnology ETF in Q3 2013 and has held it in 20 quarters since.
SeaBridge Investment Advisors's iShares Biotechnology ETF position peaked at $1.38M in Q4 2013.
954 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on SeaBridge Investment Advisors's 13F filing for Q2 2026, filed 17 Jul 2026.